Epsilon Imaging Inc. has received the CE mark for its EchoInsight visualization and analysis platform with practical strain imaging for improved quality, standardization and workflow in echocardiography interpretation. The CE mark will allow EchoInsight to be sold in the European Union.

To assist providers in managing high-dollar inventory, McKesson has introduced radio frequency identification (RFID) cabinets as part of McKesson Point of Use Supply.  The vendor-neutral cabinets now integrate with clinical workflow to better support patient safety while making it easier for providers to monitor inventory and manage expenses, particularly in high-cost specialty areas like cardiology, radiology and operating room (OR) departments. 


GE Healthcare has initiated a Class I recall of all its nuclear imaging systems and called for its systems to not be operated until the vendor can inspect the scanner. The recall follows the death of a patient after a portion of the scanner fell onto the patient during the scan on an Infinia Hawkeye 4 system at a VA medical center facility in the United States.
How to evaluate new cardiac technology

There is a “new normal” for the global medical device market where financial constraints increasingly impact both treatment and purchasing decision-making. As a result, companies develop products that demonstrate improved clinical outcomes and continue to provide services that raise the quality and efficiency of healthcare delivery in an increasingly resource-constrained environment.

The Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) clearance, CE mark and Japan PMDA approval for its OptiCross Coronary Imaging Catheter and has launched the device in the United States and Europe. A launch in Japan is planned for later this month. OptiCross, a next generation intravascular ultrasound (IVUS) catheter, offers better deliverability and higher resolution imaging to facilitate complex coronary procedures.

 


Myocardial perfusion imaging (MPI) with positron emission tomography (PET) has been shown to be superior to single photon emission computed tomography (SPECT). Nevertheless, widespread clinical use of PET MPI has been limited by the currently available PET myocardial perfusion tracers. 

Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, new information systems that leverage natural language and changing market conditions.

Heart IT has released version 8 of its flagship products: WebPax picture archive and communications system (PACS) and remote viewing system, Universal Viewer.

Merck announced that the New Drug Application (NDA) for its investigational anti-thrombotic medicine, vorapaxar, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now